Tumor lysis with LTX-401 creates anticancer immunity
Sign Up to like & getrecommendations! Published in 2019 at "OncoImmunology"
DOI: 10.1080/2162402x.2019.1594555
Abstract: ABSTRACT Local immunotherapies such as the intratumoral injection of oncolytic compounds aim at reinstating and enhancing systemic anticancer immune responses. LTX-315 is a first-in-class, clinically evaluated oncolytic peptide-based local immunotherapy that meets these criteria. Here,… read more here.
Keywords: creates anticancer; ltx 401; lysis ltx; anticancer immunity ... See more keywords